Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 8, Number 3, May 2010

Articles

Dyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic Factors
pp. 301-326(26)
Authors: E. Toms, Tracey; P. Symmons, Deborah; D. Kitas, George

Favourites:
ADD

The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus
pp. 327-337(11)
Authors: Anfossi, Giovanni; Russo, Isabella; Bonomo, Katia; Trovati, Mariella

Favourites:
ADD

The Axis of Thrombospondin-1, Transforming Growth Factor Beta and Connective Tissue Growth Factor: An Emerging Therapeutic Target in Rheumatoid Arthritis
pp. 338-343(6)
Authors: C. Rico, Mario; J. Rough, James; E. Del Carpio-Cano, Fabiola; P. Kunapuli, Satya; A. DeLa Cadena, Raul

Favourites:
ADD

Aliskiren, a Direct Renin Inhibitor, in Clinical Practice: A New Approach in the Treatment of Hypertension
pp. 344-362(19)
Authors: Moutzouri, Elisavet; Florentin, Matilda; S. Elisaf, Moses; P. Mikhailidis, Dimitri; N. Liberopoulos, Evangelos

Favourites:
ADD

Cilostazol in the Management of Atherosclerosis
pp. 363-372(10)
Authors: Sallustio, Fabrizio; Rotondo, Federica; Di Legge, Silvia; Stanzione, Paolo

Favourites:
ADD

New Anticoagulants for Prevention and Treatment of Venous Thromboembolism
pp. 373-382(10)
Authors: N. Roberts, Lara; Arya, Roopen

Favourites:
ADD

Silence of the Limbs: Pharmacological Symptomatic Treatment of Intermittent Claudication
pp. 383-387(5)
Authors: De Backer, Tine; Vander Stichele, Robert; De Buyzere, Marc; De Backer, Guy; Van Bortel, Lucas

Favourites:
ADD

Cardiac Biomarkers in Acute Coronary Syndromes: A Review
pp. 388-393(6)
Authors: Amodio, Gianfranco; Antonelli, Gianfranco; Di Serio, Francesca

Favourites:
ADD

CGRP, a Vasodilator Neuropeptide that Stimulates Neuromuscular Transmission and EC Coupling
pp. 394-403(10)
Authors: Victoria Vega, Ana; Avila, Guillermo

Favourites:
ADD
Favourites:
ADD

Pulmonary Arterial Hypertension
pp. 412-420(9)
Authors: Burt, Christiana; Pepke-Zaba, Joanna; Falter, Florian

Favourites:
ADD

ErbB Targeted Drugs and Angiogenesis
pp. 421-431(11)
Authors: Iivanainen, Erika; Elenius, Klaus

Favourites:
ADD

Personalized Medicine in Psoriasis: Concept and Applications
pp. 432-436(5)
Author: A. Al-Hoqail, Ibrahim

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more